echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Qian Feng's research group from the School of Pharmacy, Tsinghua University published the latest scientific article in "Theranostics" "Macropinocytosis dextran assists the targeted delivery of drugs in KRAS-mutant pancreatic cancer"

    Qian Feng's research group from the School of Pharmacy, Tsinghua University published the latest scientific article in "Theranostics" "Macropinocytosis dextran assists the targeted delivery of drugs in KRAS-mutant pancreatic cancer"

    • Last Update: 2022-03-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
     


    70kDa dextran has the potential to better target KRAS

    Figure 1 70kDa Dextran has more significant KRAS targeting (A: 4kDa Dextran, B: 70kDa Dextran, C: 150kDa Dextran)

    Conjugation of drugs to dextran enhances selectivity of drug delivery to KRAS-mutant cancer cells





    Figure 2 DEX-TP enhances the toxicity against KRAS mutant pancreatic cancer cells and the ability to inhibit tumor growth 
    DEX-TP effectively inhibits the progression of orthotopic pancreatic tumors



    Figure 3.
    DEX-TP increases the inhibition of pancreatic orthotopic MIAPaCa-2 tumor growth

    DEX-TP prolongs survival in KPC-transplanted mice and alleviates the immune depletion of TP


    Figure 4 Therapeutic effect of DEX-TP on KPC xenograft orthotopic tumor model

    Challenges and Prospects




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.